The Latin American Association of Cardiac and Endovascular Surgery Statement Regarding the Recently Released 2020 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease
Restricted accessResearch articleFirst published online September, 2021
The Latin American Association of Cardiac and Endovascular Surgery Statement Regarding the Recently Released 2020 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease
OttoCM.NishimuraRA.BonowROet al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation2021; 143: e35–e71.33332149
2.
LeonMB.SmithCR.MackMJet al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med2016; 374: 1609–1620.27040324
3.
StoneGW.LindenfeldJ.AbrahamWTet al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med2018; 379: 2307–2318.30280640
4.
ObadiaJ-F.Messika-ZeitounD.LeurentGet al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med2018; 379: 2297–2306.30145927
5.
FeldmanT.KarS.ElmariahSet al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol2015; 66: 2844–2854.26718672